153.87 Opioid and methamphetamine data system.
325 words·~1 min read·
/wi/chapter-153/153-87-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
153.87 Opioid and methamphetamine data system.
(1)Subject to sub.
(3), the department of administration shall issue a request for proposals to establish and maintain an opioid and methamphetamine data system to collect, format, analyze, and disseminate information on opioid and methamphetamine use, which shall include all of the following:
(a)Hospital discharge data from visits and stays related to opioid use or overdose.
(b)Hospital discharge data from visits and stays related to methamphetamine use or overdose.
(c)Ambulance service run data related to opioid use or overdose.
(d)The number of opioid-related overdoses in the state, the number of individuals who overdose on opioids, and the opioids on which the individuals overdose.
(e)The number of methamphetamine-related overdoses in the state, the number of individuals who overdose on methamphetamines, and the forms of methamphetamines on which the individuals overdose.
(f)Death records related to opioid use or overdose.
(g)Death records related to methamphetamine use or overdose.
(h)The number of opioid treatment centers in the state, by the owner or operator of each opioid treatment center.
(i)The number of methamphetamine treatment centers in the state, by the owner or operator of each methamphetamine treatment center.
(j)The number of providers in this state that are allowed to prescribe a drug that is a combination of buprenorphine and naloxone, the patient capacity for those prescribers, the number of patients taking such a combination drug, and the number of patients who have discontinued such a combination drug due to successful completion of a treatment program.
(k)The number of methadone clinics in the state, the number of patients taking methadone, the number of patients who more than once have been on courses of methadone, the number of patients who have discontinued methadone use due to successful completion of a treatment program, and the number of patients who are receiving methadone treatment for each of the following durations:
1. Longer than 12 months.